Music for Pain and Dementia

NCT07602283 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-22

No results posted yet for this study

Summary

This study aims to provide mechanistic insights into how group drumming as a music-based intervention (MBI) affects pain responses and nociceptive function in individuals with Alzheimer's Disease (AD), mild dementia or mild cognitive impairment (MCI). Heart rate (HR), heart rate variability (HRV), and brain activity will be measured during communal drumming with their dyadic partners and others. Brain activity, blood pressure, cognitive abilities, blood hormone levels, and static and dynamic pain will also be measured during sessions pre and post the 8-week community drum circle. Investigators will leverage various measurement techniques including, but not limited to, electroencephalography (EEG), quantitative sensory testing (QST), behavioral, surveys, and physiological monitoring to study the impact of group drumming on pain and brain activity in AD and inter-dyad synchrony.

Conditions

Interventions

BEHAVIORAL

Drumming session

A 45-minute to 1-hour group drumming session

BEHAVIORAL

Music-listening session

A 45-minute to 1-hour group music-listening session

Sponsors & Collaborators

  • Renée Fleming Foundation

    collaborator UNKNOWN
  • Yale University School of Medicine, Department of Psychiatry

    collaborator UNKNOWN
  • Howard University

    collaborator OTHER
  • NeuroArts Blueprint Initiative

    collaborator UNKNOWN
  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH
  • Yale University

    lead OTHER

Principal Investigators

  • AZA Allsop, MD, PhD · Yale University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-08-01
Completion
2028-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07602283 on ClinicalTrials.gov